Immunotherapy (Checkpoint Inhibitors)
Darzalex (daratumumab) in Oman — Regulatory and Supply Information
Anti-CD38 monoclonal antibody for multiple myeloma — first-line in transplant-eligible and ineligible patients (with VRd, Rd or Vd), relapsed / refractory settings, and also indicated in light-chain (AL) amyloidosis. Subcutaneous formulation (Darzalex Faspro / SC) allows 5-minute administration.
Prescription-only medicine. No pricing is published on this page. Prescription-medicine pricing is not advertised to the public in this market.
This page is informational and is not an advertisement, a promotional communication, or medical advice. It does not offer any medicine for sale to the public. Treatment decisions belong to your treating physician.
What this medicine is
- Active ingredient
- daratumumab
- Marketing authorisation holder
- Janssen (Johnson & Johnson)
- Therapeutic class
- Immunotherapy (Checkpoint Inhibitors)
Presentations and dosage forms
- 100 mg / 5 mL vial
- 400 mg / 20 mL vial (IV)
- 1800 mg / 15 mL SC (Darzalex Faspro)
Storage, cold chain and handling
Refrigerate 2–8°C, protect from light, do not freeze or shake.
The regulatory position in Oman
Medicines in the Sultanate of Oman are regulated by the Ministry of Health, through the Directorate General of Pharmaceutical Affairs and Drug Control. Registration, importation, storage and distribution of pharmaceutical products all fall within that directorate's remit, and every product described on this page is a prescription-only medicine.
We have not verified Oman's personal-import procedure from a primary source, so we do not describe one. There is no step-by-step process set out on this page and nothing here should be read as an account of what the Ministry requires. Requirements must be confirmed directly with the Ministry of Health before any step is taken.
What we can describe is the general concept that applies across the region: a named-patient supply. A named-patient supply is a quantity of a prescription medicine intended for one identified patient, requested by that patient's treating physician, documented by a prescription and a medical report, and handled through licensed channels with the cold chain and batch traceability intact. It is not a commercial sale to the public and it is not a substitute for a locally registered product where one is available.
Assembling the documentation below before approaching the Ministry usually shortens the exchange, whichever route the Directorate General confirms applies to a given product.
We have not verified Oman's personal-import procedure. We do not describe one here. Confirm the current requirements with the Ministry of Health, Directorate General of Pharmaceutical Affairs and Drug Control.
Documentation typically required
- A valid prescription from the treating physician, naming the trade name, active ingredient, concentration and quantity
- A medical report describing the diagnosis and the treatment plan
- Proof of identity for the patient
- Confirmation from the treating clinician of the quantity required for the treatment course
- For a hospital or clinic: the establishment licence and the request of the responsible pharmacist
Official sources
Why the same medicine is priced differently in Türkiye
This is how the Turkish pricing system works. These are published facts about a state mechanism, not a claim about what we charge.
- Turkish medicine prices are calculated from a fixed pharmaceutical euro rate rather than the spot exchange rate. Under Decision No. 11031 (Resmî Gazete 33194, 12 March 2026) that rate is set at 65% of the previous year's average Turkish Central Bank euro selling rate.
- The reference price is derived from the lowest ex-factory price in a basket of five to ten EU member states designated by the Ministry of Health.
- A mandatory public discount of roughly 28–41% is then applied, depending on the product category and price band. The band thresholds change with each SUT revision, so we do not reproduce them here.
Official published lists — our figures appear nowhere
We publish no price. Each authority below publishes its own list. Read them directly:
- TİTCK — Türkiye Medicines and Medical Devices Agency, published price list
- Ministry of Health, Sultanate of Oman
- Directorate General of Pharmaceutical Affairs and Drug Control (MOH Oman)
Compare them yourself.
For international context: RAND Corporation, analysing 2022 data and publishing in February 2024, found US prices were 278% of prices in 33 other high-income countries, rising to 422% for brand-name originator medicines.
How to obtain a price
We do not publish prices. The price depends on the dose, the number of vials and the number of treatment cycles. Send your prescription and medical report and you will receive a written quote within 24 hours.
Sourced through Türkiye pharmacy channels · İTS serial-traceable — every Turkish pack carries an İTS karekod encoding the GTIN, serial number, batch and expiry, which can be checked against Türkiye's Pharmaceutical Track and Trace System.
How to obtain a priceSearch terms for this medicine
The same molecule is searched under several names. All of the following refer to the same product:
- Darzalex
- daratumumab
- دارزالكس
- داراتوموماب
- Darzalex Oman
- دارزالكس سلطنة عُمان
- daratumumab MOH Oman
- Darzalex prescription
- دارزالكس وصفة طبية
Frequently asked questions
Prescription-based enquiry
If you hold a valid prescription from a treating physician in Oman, you can send us the prescription details and we will reply with the regulatory and documentation position for that specific product. We do not publish pricing for Oman and we do not sell to the public.
Send a prescription-based enquiryBackground reading
- Why medicines cost less in Türkiye
- How to verify a medicine is genuine
- WHO falsified medicine alerts
- Named patient supply
- For healthcare professionals
- Import guide — Oman
- Hospital & procurement — Oman
- Oman medicines
- Darzalex — Saudi Arabia
- Darzalex — Kuwait
- Darzalex — Bahrain
- Darzalex — United Arab Emirates
- Darzalex — Qatar
- Darzalex — Azerbaijan
Related medicines
Medically reviewed by Pharmacy Remedy Pharmacovigilance & Compliance Desk · Last updated: 2026-07-29 · Ministry of Health — Directorate General of Pharmaceutical Affairs and Drug Control
For healthcare professionals
Prescribers, hospital and specialty pharmacies, oncology centres and procurement departments: named patient supply, documentation and the sourcing workflow.